E160 - (CME) Novel Agents for Treating Major Depressive Disorder (MDD)
NEI Podcast
00:00
Dextromathorfen: A Novel Antidepressant
In phase three development right now, the concept here is almost like an oral ketamine-like drug. There's another one in development, which is a form of dextromathorfen. And again, the initial study that is randomized and controlled, it looks quite effective.
Transcript
Play full episode
